中商官网
研究报告
康哲药业（HK0867）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 现金及现金等价物净增加额 |
-60759.50 | -6444.70 | 97512.70 | 71593.49 | 130365.00 | 55059.59 | -3943.50 | 37263.70 | 25076.70 | -1822.20 | -24295.00 | -18462.40 | 850.60 |
| 经营活动现金流量净额 |
126854.70 | 250285.30 | 355324.30 | 249385.20 | 269202.70 | 255511.90 | 175456.50 | 207179.80 | 116204.40 | 61455.20 | 84319.80 | 33483.20 | 6979.00 |
| 投资活动现金流量净额 |
-61509.60 | -44227.60 | -117820.20 | -151952.50 | -35382.10 | -30938.60 | -23968.90 | -35409.90 | -153325.80 | -85250.30 | -93621.10 | -17490.50 | -5297.70 |
| 融资活动现金流量净额 |
-126104.60 | -212502.40 | -139991.40 | -25839.20 | -103455.60 | -169513.70 | -155431.10 | -134506.20 | 62198.10 | 21972.90 | -14993.70 | -34455.10 | -830.70 |
| 现金及现金等价物期末余额 |
370650.10 | 431105.80 | 437637.60 | 338573.90 | 266842.60 | 136500.80 | 81508.10 | 85562.90 | 48245.10 | 22933.60 | 24351.50 | 48794.30 | 10716.20 |
| 经营活动现金流量净额 |
126854.70 | 250285.30 | 355324.30 | 249385.20 | 269202.70 | 255511.90 | 175456.50 | 207179.80 | 116204.40 | 61455.20 | 84319.80 | 33483.20 | 6979.00 |
| 折旧与摊销 |
25923.80 | 22956.50 | 22722.60 | 21789.10 | 20638.70 | 20212.60 | 19899.40 | 19641.80 | 17585.90 | 7775.10 | 4244.80 | 3652.60 | 520.80 |
| 营运资金变动 |
-12814.80 | 297.00 | 9007.50 | -59607.40 | 8838.00 | 15622.00 | -37732.40 | 13318.60 | -51077.30 | -42397.00 | -3440.90 | -32736.60 | -1800.80 |
| 投资活动现金流量净额 |
-61509.60 | -44227.60 | -117820.20 | -151952.50 | -35382.10 | -30938.60 | -23968.90 | -35409.90 | -153325.80 | -85250.30 | -93621.10 | -17490.50 | -5297.70 |
| 资本性支出 |
45590.80 | 31796.00 | 52492.10 | 18484.10 | 34142.10 | 34047.30 | 6197.20 | 7662.40 | 114569.20 | 58065.00 | 29151.40 | 14774.70 | 1099.60 |
| 投资购买 |
-34287.10 | -37801.50 | -45925.30 | -86853.49 | -171.50 | -273.60 | -23095.30 | -2629.10 | -- | -27918.00 | -15464.40 | -- | -- |
| 融资活动现金流量净额 |
-126104.60 | -212502.40 | -139991.40 | -25839.20 | -103455.60 | -169513.70 | -155431.10 | -134506.20 | 62198.10 | 21972.90 | -14993.70 | -34455.10 | -830.70 |
| 股份回购 |
-23839.40 | -11630.00 | -4838.20 | -15151.90 | -8696.30 | -- | -5302.00 | -- | -- | -- | -- | -- | -- |
| 支付股息 |
-55616.20 | -143424.90 | -127623.90 | -115483.40 | -83412.90 | -82275.20 | -72851.50 | -61111.70 | -46287.60 | -36960.40 | -29101.60 | -24250.70 | -2845.40 |
| 股票发行 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | 67883.80 | -- | -- | -- |
| 现金及现金等价物净增加额 |
-60759.50 | -6444.70 | 97512.70 | 71593.49 | 130365.00 | 55059.59 | -3943.50 | 37263.70 | 25076.70 | -1822.20 | -24295.00 | -18462.40 | 850.60 |
| 加：现金及现金等价物期初余额 |
431105.80 | 437637.60 | 338573.90 | 266842.60 | 136500.80 | 81508.10 | 85562.90 | 48245.10 | 22933.60 | 24351.50 | 48794.30 | 67356.70 | 9790.60 |
| 汇率变动对现金及现金等价物的影响 |
303.80 | -87.10 | 1551.00 | 137.80 | -23.20 | -66.90 | -111.30 | 54.10 | 234.80 | 404.30 | -147.80 | -100.00 | 75.00 |
| 现金及现金等价物期末余额 |
370650.10 | 431105.80 | 437637.60 | 338573.90 | 266842.60 | 136500.80 | 81508.10 | 85562.90 | 48245.10 | 22933.60 | 24351.50 | 48794.30 | 10716.20 |